NEREUSRX
LIVE

Serial Number

99694011

Owner

Vanda Pharmaceuticals Inc.

Attorney

Jayme M Torelli

Filing Date

Mar 10, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NEREUSRX Trademark

Serial Number: 99694011

NEREUSRX is a trademark filed by Vanda Pharmaceuticals Inc. on March 10, 2026. The trademark is classified under Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Vanda Pharmaceuticals Inc. (104 trademarks)

Suite 300
Rockville, MD 20850

Entity Type: 03

Trademark Details

Filing Date

March 10, 2026

Registration Date

Not Registered

Published for Opposition

May 26, 2026

Goods & Services

Pharmaceutical services, namely, processing online and telephone prescription orders in retail and central fill pharmacies; Providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciences; Pharmaceutical cost management services and drug utilization review services; Retail pharmacy services; Specialized retail pharmacy services for patients with particular medical conditions; Mail order pharmacy services; Outsourcing services in the nature of arranging the purchase of prescription drugs for consumers

Pharmacists' services to make up prescriptions; Dispensing of pharmaceuticals; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Preparation of prescriptions by pharmacists; Preparation of prescriptions in pharmacies

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 27, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 27, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 27, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 27, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 27, 2026 CNEA
ASSIGNED TO EXAMINER
Apr 17, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 10, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2026 NWOS
NEW APPLICATION ENTERED
Mar 10, 2026 NWAP